The Firm

Horn & Co. is the leading Israeli boutique law firm in the field of hi-tech and life sciences, and is unique in its exclusive practice and expertise in this field. The firm’s practice in life sciences began in 1994, when Yuval Horn represented Orgenics Ltd. (founded by Prof. Max Herzberg) in its sale to SelfCare, Inc. Since then, both Mr. Horn and his colleagues have represented numerous founders, companies and investors in their transactions in the life science sector. Horn & Co.’s expertise includes the representation of clients in all aspects of their operations, including especially their technology and intellectual property transactions, their commercial contracting and their corporate and funding matters. Clients range from start up companies to multi billion international companies.

Horn & Co. was founded in 2010 and currently employs 15 lawyers and three articled clerks. Our experience in complex cross-border, technology and corporate finance transactions allows us to design cost-effective innovative structures, solutions and advice.

Horn & Co. partners and associates have been recognized by international publications and peers as experts in corporate law, intellectual property and technology transactions. In 2013, and also in 2015, Yuval Horn was recognized by the International Who’s Who of Life Sciences Lawyers as one of the five leading worldwide individuals in life sciences transactions. Mr. Horn has been recognized as an expert in life sciences by the International Who’s Who of Life Sciences Lawyers during the years 2008-2014.

Since 2008 he has been a member and legal advisor of the Sheba IRB (Helsinki Committee). Yuval currently serves as the Co-Chair of the International Bar Association Technology Law Committee.

Yuval is frequently asked to talk and write about his areas of expertise. He has most recently chaired the keynote panel and Corporate Finance panel at the IBA World Life Sciences Conference in Philadelphia (June, 2015) and a panel about the legal implications of computer aided analysis of genetic structures at the Annual IBA conference in Vienna Austria (October, 2015). In addition, Yuval was requested to draft commentary on key issues facing transactional specialists as one of the leading practitioners in the world in Who’s Who Legal: Life Sciences, 2015 and 2016, and participated in a round table on key issues in softward development in the Who’s Who Legal: TMT (forthcoming, 2016).